{"entity":{"type":"insider","cik":"0001465835","url":"/insider/0001465835","json_url":"/insider/0001465835.json","name":"Fuglesang Christopher","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":6,"first":"2017-01-10","last":"2023-08-15","span_basis":"filed_date"},"name_variants":[{"name":"Fuglesang Christopher","source":"filing","n_filings":6,"first_seen":"2017-01-10","last_seen":"2023-08-15"}],"transactions":[{"id":8644021,"accession":"0000895345-23-000499","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000895345-23-000499","line_url":"/filing/0000895345-23-000499#line-2","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"Boxer Asset Management Inc.; Boxer Capital, LLC; Davis Aaron I.; Dissanayake Shehan Bharatha; Fuglesang Christopher; LEWIS JOSEPH; MVA Investors, LLC","owner_url":null,"role":"Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1201440.0,"shares_display":"1,201,440","price_per_share":27.8,"price_display":"27.80","price_state":"stated","total_value":33400032.0,"total_display":"33,400,032.00","shares_owned_after":3201440.0,"shares_owned_after_display":"3,201,440","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-11","filed_date":"2023-08-15","scope":"insider"},{"id":8644019,"accession":"0000895345-23-000499","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000895345-23-000499","line_url":"/filing/0000895345-23-000499#line-1","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"Boxer Asset Management Inc.; Boxer Capital, LLC; Davis Aaron I.; Dissanayake Shehan Bharatha; Fuglesang Christopher; LEWIS JOSEPH; MVA Investors, LLC","owner_url":null,"role":"Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":57533.0,"shares_display":"57,533","price_per_share":27.8,"price_display":"27.80","price_state":"stated","total_value":1599417.4,"total_display":"1,599,417.40","shares_owned_after":287866.0,"shares_owned_after_display":"287,866","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-11","filed_date":"2023-08-15","scope":"insider"},{"id":8421038,"accession":"0000895345-23-000500","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000895345-23-000500","line_url":"/filing/0000895345-23-000500#line-2","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"Boxer Asset Management Inc.; Boxer Capital, LLC; Davis Aaron I.; Dissanayake Shehan Bharatha; Fuglesang Christopher; LEWIS JOSEPH; MVA Investors, LLC","owner_url":null,"role":"Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1201440.0,"shares_display":"1,201,440","price_per_share":27.8,"price_display":"27.80","price_state":"stated","total_value":33400032.0,"total_display":"33,400,032.00","shares_owned_after":3201440.0,"shares_owned_after_display":"3,201,440","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-11","filed_date":"2023-08-15","scope":"insider"},{"id":8421035,"accession":"0000895345-23-000500","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000895345-23-000500","line_url":"/filing/0000895345-23-000500#line-1","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"Boxer Asset Management Inc.; Boxer Capital, LLC; Davis Aaron I.; Dissanayake Shehan Bharatha; Fuglesang Christopher; LEWIS JOSEPH; MVA Investors, LLC","owner_url":null,"role":"Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":57533.0,"shares_display":"57,533","price_per_share":27.8,"price_display":"27.80","price_state":"stated","total_value":1599417.4,"total_display":"1,599,417.40","shares_owned_after":287866.0,"shares_owned_after_display":"287,866","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-11","filed_date":"2023-08-15","scope":"insider"},{"id":4350749,"accession":"0000899243-21-010812","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-21-010812","line_url":"/filing/0000899243-21-010812#line-6","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"MVA Investors, LLC; Fuglesang Christopher; LIEBERBURG IVAN M; Boxer Asset Management Inc.; Dissanayake Shehan Bharatha; LEWIS JOSEPH; Davis Aaron I.; Boxer Capital, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":363000.0,"shares_display":"363,000","price_per_share":181.15,"price_display":"181.15","price_state":"stated","total_value":65757450.0,"total_display":"65,757,450.00","shares_owned_after":2000000.0,"shares_owned_after_display":"2,000,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-05","filed_date":"2021-03-09","scope":"insider"},{"id":4350742,"accession":"0000899243-21-010812","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-21-010812","line_url":"/filing/0000899243-21-010812#line-5","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"MVA Investors, LLC; Fuglesang Christopher; LIEBERBURG IVAN M; Boxer Asset Management Inc.; Dissanayake Shehan Bharatha; LEWIS JOSEPH; Davis Aaron I.; Boxer Capital, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37000.0,"shares_display":"37,000","price_per_share":181.15,"price_display":"181.15","price_state":"stated","total_value":6702550.0,"total_display":"6,702,550.00","shares_owned_after":230333.0,"shares_owned_after_display":"230,333","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-05","filed_date":"2021-03-09","scope":"insider"},{"id":4350737,"accession":"0000899243-21-010812","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-010812","line_url":"/filing/0000899243-21-010812#line-4","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"MVA Investors, LLC; Fuglesang Christopher; LIEBERBURG IVAN M; Boxer Asset Management Inc.; Dissanayake Shehan Bharatha; LEWIS JOSEPH; Davis Aaron I.; Boxer Capital, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4.0,"shares_display":"4","price_per_share":181.0,"price_display":"181.00","price_state":"stated","total_value":724.0,"total_display":"724.00","shares_owned_after":2363000.0,"shares_owned_after_display":"2,363,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-05","filed_date":"2021-03-09","scope":"insider"},{"id":4350728,"accession":"0000899243-21-010812","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-21-010812","line_url":"/filing/0000899243-21-010812#line-3","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"MVA Investors, LLC; Fuglesang Christopher; LIEBERBURG IVAN M; Boxer Asset Management Inc.; Dissanayake Shehan Bharatha; LEWIS JOSEPH; Davis Aaron I.; Boxer Capital, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1.0,"shares_display":"1","price_per_share":181.0,"price_display":"181.00","price_state":"stated","total_value":181.0,"total_display":"181.00","shares_owned_after":267333.0,"shares_owned_after_display":"267,333","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-05","filed_date":"2021-03-09","scope":"insider"},{"id":2908017,"accession":"0000899243-20-030060","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-20-030060","line_url":"/filing/0000899243-20-030060#line-6","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"LEWIS JOSEPH; Boxer Asset Management Inc.; Dissanayake Shehan Bharatha; LIEBERBURG IVAN M; Davis Aaron I.; Boxer Capital, LLC; MVA Investors, LLC; Fuglesang Christopher","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":362950.0,"shares_display":"362,950","price_per_share":202.0,"price_display":"202.00","price_state":"stated","total_value":73315900.0,"total_display":"73,315,900.00","shares_owned_after":1404610.0,"shares_owned_after_display":"1,404,610","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-30","filed_date":"2020-10-30","scope":"insider"},{"id":2908014,"accession":"0000899243-20-030060","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-20-030060","line_url":"/filing/0000899243-20-030060#line-5","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"LEWIS JOSEPH; Boxer Asset Management Inc.; Dissanayake Shehan Bharatha; LIEBERBURG IVAN M; Davis Aaron I.; Boxer Capital, LLC; MVA Investors, LLC; Fuglesang Christopher","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37050.0,"shares_display":"37,050","price_per_share":202.0,"price_display":"202.00","price_state":"stated","total_value":7484100.0,"total_display":"7,484,100.00","shares_owned_after":216288.0,"shares_owned_after_display":"216,288","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-30","filed_date":"2020-10-30","scope":"insider"},{"id":2245180,"accession":"0000899243-20-019882","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-019882","line_url":"/filing/0000899243-20-019882#line-2","is_derivative":false,"issuer_cik":"0001465835","issuer_name":"Pandion Therapeutics, Inc.","issuer_ticker":"PAND","issuer_name_source":null,"issuer_url":"/issuer/0001465835","owner_cik":"0001465835","owner_name":"Fuglesang Christopher","owner_url":"/insider/0001465835","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":722222.0,"shares_display":"722,222","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":12999996.0,"total_display":"12,999,996.00","shares_owned_after":2600773.0,"shares_owned_after_display":"2,600,773","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-07-21","filed_date":"2020-07-21","scope":"insider"},{"id":4645621,"accession":"0000899243-17-000987","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-17-000987","line_url":"/filing/0000899243-17-000987#line-2","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"LAPPE RODNEY W; LEWIS JOSEPH; Boxer Capital, LLC; Davis Aaron I.; Reisman Neil; MVA Investors, LLC; Boxer Asset Management Inc.; Dissanayake Shehan Bharatha; LIEBERBURG IVAN M; Fuglesang Christopher","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":280059.0,"shares_display":"280,059","price_per_share":5.6,"price_display":"5.60","price_state":"stated","total_value":1568330.4,"total_display":"1,568,330.40","shares_owned_after":1037994.0,"shares_owned_after_display":"1,037,994","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-06","filed_date":"2017-01-10","scope":"insider"},{"id":4645614,"accession":"0000899243-17-000987","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-000987","line_url":"/filing/0000899243-17-000987#line-1","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"LAPPE RODNEY W; LEWIS JOSEPH; Boxer Capital, LLC; Davis Aaron I.; Reisman Neil; MVA Investors, LLC; Boxer Asset Management Inc.; Dissanayake Shehan Bharatha; LIEBERBURG IVAN M; Fuglesang Christopher","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6104.0,"shares_display":"6,104","price_per_share":5.6,"price_display":"5.60","price_state":"stated","total_value":34182.4,"total_display":"34,182.40","shares_owned_after":435444.0,"shares_owned_after_display":"435,444","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-06","filed_date":"2017-01-10","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":1,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":1},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001576263","name":"Mirati Therapeutics, Inc.","url":"/issuer/0001576263","role":"Ten percent owner, Other","n_filings":5,"first_seen":"2017-01-10","last_seen":"2023-08-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001807901","name":"Pandion Therapeutics, Inc.","url":"/issuer/0001807901","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2020-07-21","last_seen":"2020-07-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001465835","retrieved_at":"2026-08-21T15:23:55+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}